Bio-Solutions Continues Pursuit of $25 Billion Diabetes Marketplace (BISU)

The stock of Bio-Solutions (OTC: BISU) staged a solid rally today as the company updated shareholders on its progress of entering the $25 billion diabetes marketplace. Bio-Solutions rose 7.7%, closing at a share price of $0.021. With 1.11 million shares exchanging hands compared to its daily average of 81,710, the stock also traded at a high volume today.

Bio-Solutions now has a total gain of 114.3% since the start of 2012. The stock had a huge breakout on January 31, 2012, trading to an annual high of $0.059 per share. The stock declined since that point and experienced a few mini-breakouts in recent months.

Since the acquisition Type2 Defense in September 2011, Bio-Solutions has engaged in running a test trail of the T2 product in an American suburban community. The purpose of this test trail is to gauge the response and feedback from a segment of the population towards the Type2 Defense product.

Type2 Defense is a glucose-control dietary supplement powder formulated to help support healthy glucose levels, in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for Type II Diabetics and Pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

On July 30, 2012, Bio-Solutions announced that the company had started production of the recently acquired Type2 Defense, pursuing the $25 billion type II and pre-diabetic marketplace.

There are 11 promotions listed on for Bio Solutions. Stock Plays Online promoted Bio-Solutions today, and was compensated $2000 from a non-affiliate third party. On Twitter, @pennystock24 mentioned that Investor Chat Room also promoted Bio Solutions today.

Other notable recent headlines for Bio-Solutions include:

  • Yesterday, August 7, 2012: Bio-Solutions announced the addition of Ms. Dana Kraft as a team member.
  • June 19, 2012: As Bio-Solutions launched Type2 Defense, a state-of-the-art functional beverage for the management of Type 2 diabetes, President and CEO Bill Gallagher announced that the company moved the corporate headquarters from Montreal, Canada to San Antonio, Texas, which placed Bio-Solutions at the geographic hub of cutting-edge research in the fight against diabetes.

Incorporated on March 27, 2007, Bio-Solutions is a development stage company. The company’s supplier for the raw material used in its Nutra-Animal blend is called Oceanutrasciences, also known as Aqua-Biokem. Its primary market is chicken integrators, as well as chicken feed manufacturers in Canada.

For consideration of being featured on WallstreetPR, contact:

Please make sure to read and completely understand our disclaimer at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at

Published by Fiona Gibson

Fiona is a finance graduate and an expert in analyzing market trends.